Media Summary: On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the ... Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's probe into the possible side effects of ... The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker

Eli Lilly S Big Bet - Detailed Analysis & Overview

On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the ... Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's probe into the possible side effects of ... The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker

Photo Gallery

$5 BILLION bet on America: Eli Lilly brings jobs home
Eli Lilly reaches $1 trillion market value | REUTERS
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
Dr. Scott Gottlieb on weight loss drugs side effects, Eli Lilly's direct-to-consumer bet
Novo Nordisk and Eli Lilly cut obesity drug prices to compete in China | REUTERS
An Obesity shot from Eli Lilly helped some people lose 23% of body weight
Eli Lilly Is Adding $17B in Sales in One Year — Here's How
Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
Eli Lilly's Obesity Pill Moves Closer to Approval
Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook | Bloomberg Talks
FDA approves Eli Lilly's new obesity pill
View Detailed Profile
$5 BILLION bet on America: Eli Lilly brings jobs home

$5 BILLION bet on America: Eli Lilly brings jobs home

Eli Lilly

Eli Lilly reaches $1 trillion market value | REUTERS

Eli Lilly reaches $1 trillion market value | REUTERS

Eli Lilly

Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the ...

Dr. Scott Gottlieb on weight loss drugs side effects, Eli Lilly's direct-to-consumer bet

Dr. Scott Gottlieb on weight loss drugs side effects, Eli Lilly's direct-to-consumer bet

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FDA's probe into the possible side effects of ...

Novo Nordisk and Eli Lilly cut obesity drug prices to compete in China | REUTERS

Novo Nordisk and Eli Lilly cut obesity drug prices to compete in China | REUTERS

Novo Nordisk

An Obesity shot from Eli Lilly helped some people lose 23% of body weight

An Obesity shot from Eli Lilly helped some people lose 23% of body weight

A next-generation obesity shot from

Eli Lilly Is Adding $17B in Sales in One Year — Here's How

Eli Lilly Is Adding $17B in Sales in One Year — Here's How

Eli Lilly

Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS

Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS

Eli Lilly

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

Eli Lilly

Eli Lilly's Obesity Pill Moves Closer to Approval

Eli Lilly's Obesity Pill Moves Closer to Approval

Eli Lilly

Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook | Bloomberg Talks

Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook | Bloomberg Talks

Eli Lilly

FDA approves Eli Lilly's new obesity pill

FDA approves Eli Lilly's new obesity pill

The FDA has approved another obesity pill, called Foundayo, from pharmaceutical maker

Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results

Eli Lilly CEO David Ricks on Q2 earnings, obesity pill late-stage trial results

CNBC's Angelica Peebles